Hospital Universitario Hm Puerta Del Sur

At Hospital Universitario Hm Puerta Del Sur, the strongest focus is on virus diseases and bacterial infections, with studies centered on prevention and immune protection. Research includes vaccines for COVID-19, cytomegalovirus infection, urinary tract infections, and group B streptococcus disease, aiming to improve protection against common and serious infections.

• Testing new vaccine approaches for SARS-CoV-2 and emerging variants
• Evaluating prevention of UTIs, CMV, and GBS in adults, pregnant women, and infants
• Assessing safety, tolerability, and immune response in prophylactic vaccine studies

This area reflects the site’s Vaccine Research Department expertise in building better tools to prevent infection across different age groups.

The site is actively involved in nervous system diseases, especially studies on Parkinson disease and related early-stage forms. These trials explore whether new therapies can slow symptom progression, improve motor function, and support longer-term safety in people living with the disease.

• Investigating treatments for early Parkinson’s disease and idiopathic Parkinson disease
• Studying options that may delay worsening of movement and daily function
• Monitoring safety and tolerability of emerging neurological therapies

The research also includes targeted approaches for specific patient groups, showing a strong interest in more personalized care for Parkinson’s disease.

Clinical research here also covers mental disorders and symptom-focused care, including treatment-resistant depression, insomnia disorder, chronic migraine, and acute pain. The goal is to find better ways to improve quality of life when standard care is not enough.

• Testing new options for treatment-resistant depression
• Evaluating therapies for pediatric insomnia and chronic migraine
• Studying pain relief strategies for post-operative acute pain

This mix of studies highlights an interest in both symptom control and patient-centered outcomes across psychiatry and neurology.

The site participates in trials within neoplasms and hemic and lymphatic diseases, focusing on cancer treatment support and complication prevention. Research includes high-risk HER2-positive breast cancer and cancer-associated thrombosis, with the aim of improving treatment effectiveness and reducing serious risks.

• Comparing cancer therapies for HER2-positive breast cancer
• Preventing cancer-associated thrombosis in patients receiving cancer care
• Supporting safer and more effective management of cancer-related complications

These studies show that Hospital Universitario Hm Puerta Del Sur contributes to both direct cancer treatment research and supportive care research.

Research in cardiovascular diseases at this site includes prevention-focused studies that address clotting risk and overall patient safety. Rather than treating established heart disease alone, these trials look at ways to reduce complications in people undergoing other medical treatments.

• Evaluating prevention of thrombotic events in patients with cancer
• Studying treatment safety in populations at increased cardiovascular risk
• Exploring strategies that may lower serious treatment-related complications

This area connects cardiovascular medicine with broader preventive research across oncology and internal medicine.